Dabigatran is an inferior thromboembolism prophylactic treatment compared to enoxaparin
How to Cite
OrthoEvidence. Dabigatran is an inferior thromboembolism prophylactic treatment compared to enoxaparin . ACE Report. 2013;2(4):50. Available from: https://myorthoevidene.com/AceReport/Report/275
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgeryJ Arthroplasty. 2009 Jan;24(1):1-9. Epub 2008 Apr 14
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
1896 patients scheduled to undergo total knee arthroplasty were randomized to one of three thromboembolism prophylaxis treatments to determine the best prophylaxis option. Patients either received an oral 220 mg dose of dabigatran once daily, an oral 150 mg dose of dabigatran once daily, or a 30 mg injection of enoxaparin twice daily. The results from this study indicated that both treatments of d...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE